Outfit7: Sky’s the Limit in My Talking Tom 2 with the All-New Plane Builder and Sky Race

Outfit7 is blasting playtime into the stratosphere in My Talking Tom 2 with the launch of two exciting new features: Plane Builder and Sky Race. For the first time ever, fans can unleash their creativity by designing their dream flying machines and then take them into action in a thrilling aerial competition. Whether they're customizing […]

Primo Brands Announces Appointment of Eric Foss as Chairman and Chief Executive Officer

Primo BrandsCorporation (NYSE: PRMB) (“Primo Brands” or the “Company”) today announced the appointment of Eric Foss as the Company's Chairman of the Board of Directors (“Board”) and Chief Executive Officer (“CEO”) effective immediately, succeeding the Company's CEO, Robbert Rietbroek. https://mma.prnewswire.com/media/2815111/Primo_Brands_Corporation_Primo_Brands_Announces_Appointment_of_E.jpg Foss is an experienced executive, having served as Chairman and CEO of global consumer-centric businesses.

Koya Medical to Present at the Stifel 2025 Healthcare Conference in New York

Koya Medical (“Koya”), an emerging medtech innovator advancing patient-centered solutions in vascular health, has announced its participation in the Stifel 2025 Healthcare Conference on Thursday, November 13, 2025 at 4:00pm EST at the Lotte New York Palace Hotel, 4th Floor Holmes II. https://mma.prnewswire.com/media/2707057/Koya_Medical_Logo.jpg CEO Andy Doraiswamy will discuss the company's latest clinical research, strategic growth

EPAM Reports Results for Third Quarter 2025 and Raises Full Year Revenue and EPS Outlook

— Third quarter revenues of $1.394 billion, up 19.4% year-over-year — GAAP income from operations was 10.4% of revenues and non-GAAP income from operations was 16.0% of revenues for the third quarter — Third quarter GAAP diluted EPS of $1.91, a decrease of $0.46, and non-GAAP diluted EPS of $3.08, a decrease of $0.04 on

Solstice Advanced Materials Reports Third Quarter 2025 Results

— Net Sales of $969 million up 7% YoY reflecting growth in Refrigerants, Electronic Materials, and Safety & Defense Solutions — Net Loss attributable to Solstice Advanced Materials of $35 million; includes impact of costs related to spin-off from Honeywell — Adjusted Standalone EBITDA (estimate)1 of $235 million, with Adjusted Standalone EBITDA Margin (estimate)1 of

SODASTREAM® MAKES THE SEASON SPARKLE WITH NEW SPARKLING WATER MAKERS AND HOLIDAY CAMPAIGN

From Sleek New Designs to the First-Ever Sparkling Water Maker That Carbonates More Than Just Water, Sodastream ART®Mint, Sodastream MIX®, and Sodastream enso®- Black Elevate Every Celebration With Creativity, Style, and Drinks as Unique as Your Guests Sodastream® is making the holiday season sparkle brighter with three new product launches and a festive digital campaign

Cascades Reports Results for the Third Quarter of 2025

Cascades Inc. (TSX: CAS) reports its unaudited financial results for the three-month period ended September 30, 2025. Q3 2025 Highlights — Sales of $1,238 million (compared with $1,187 million in Q2 2025 and $1,201 million in Q3 2024); — Operating income of $73 million (compared with $36 million in Q2 2025 and $36 million in

Idaho® Potatoes and the American Diabetes Association® Team Up to Bust Common Nutrition Myths

In honor of American Diabetes Month, the Idaho Potato Commission (IPC) and the American Diabetes Association (ADA) are teaming up to tackle common nutrition myths about one of America's favorite foods: the potato. https://mma.prnewswire.com/media/2815192/Idaho_Potato_Commission_MashingtheMythFactSheet_ADA_APPROVED_11_4.jpg Idaho® potatoes are proud to be recognized by the American Diabetes Association's Better Choices for Life program, which helps consumers identify

Investors Are Paying Up to 35% Above the Median Sales Price, Adding Pressure for Everyday Homebuyers

Investors' share of home purchases edged higher in Q2 2025 as typical buyers pulled back amid affordability challenges Investors are continuing to impact local housing markets, both paying a premium to buy in high-cost areas and capitalizing on affordability in lower-priced regions, according to Realtor.com®'s Investor Report Mid-year Update. In Western and coastal states such

Golden Helix Launches VarSeq 3 and VSWarehouse 3

Redefining Scalability, Automation, and Clinical Yield in Genomic Interpretation Golden Helix, Inc. announced the release of VarSeq 3andVSWarehouse 3, the company's next-generation platform for secondary and tertiary genomic analysis. https://mma.prnewswire.com/media/1227873/Golden_Helix_Logo.jpg Building on more than a decade of trusted innovation, the clinical utility of VarSeq 3 has been expanded through industry partnerships and customer collaborations. This

Scroll to Top